Macrocycles expand drug discovery into previously inaccessible targets. With validated success and flexible approaches, they provide a powerful path for tackling the most challenging biology.
The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions.
Do you often need to identify unknown compounds from complex samples? ACD/MS Structure ID Suite offers a simple, replicable workflow for generating and narrowing down structural candidates.
High‑throughput scNMT‑seq offers a powerful way to map methylation and transcriptional activity. Learn about strategies that cut variability and support dependable multi‑omics datasets.
See how new technologies simplify spectral workflows, enable seamless panel transfer, and deliver deeper biological resolution for high-parameter analysis—making experiments more accessible.
Gain precise quantification for CGT workflows with a simple, automated digital PCR approach that improves sensitivity, minimizes hands‑on time, and supports evolving demands from discovery through QC.
Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.
Early identification of potential absorption risks is critical for rapid and efficient drug development. Discover PBPK modeling services designed to de-risk your drug development program.
